title: [A case of malignant insulin-producing pancreatic tumor treatment].
authors.forename: E V
authors.initials: EV
authors.lastname: Reutova
authors.forename: N F
authors.initials: NF
authors.lastname: Orel
authors.forename: N S
authors.initials: NS
authors.lastname: Besova
authors.forename: E V
authors.initials: EV
authors.lastname: Artemova
authors.forename: N B
authors.initials: NB
authors.lastname: Smirnova
authors.forename: V A
authors.initials: VA
authors.lastname: Gorbunova
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000097:blood; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D007340:Insulinoma / Q000188:drug therapy / Q000378:metabolism* / Q000556:secondary; D008113:Liver Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000556:secondary; D008875:Middle Aged; D009607:Nitrosourea Compounds / Q000627:therapeutic use*; D015282:Octreotide / Q000627:therapeutic use*; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology
chemical_list: C113217:3-arabinopyranosyl-1-methyl-1-nitrosourea; D018931:Antineoplastic Agents, Hormonal; D014408:Biomarkers, Tumor; D007328:Insulin; D009607:Nitrosourea Compounds; D015282:Octreotide